These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 19027299)

  • 1. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development.
    Morrison DK
    Trends Cell Biol; 2009 Jan; 19(1):16-23. PubMed ID: 19027299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14-3-3 Proteins: diverse functions in cell proliferation and cancer progression.
    Freeman AK; Morrison DK
    Semin Cell Dev Biol; 2011 Sep; 22(7):681-7. PubMed ID: 21884813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14-3-3 proteins as signaling integration points for cell cycle control and apoptosis.
    Gardino AK; Yaffe MB
    Semin Cell Dev Biol; 2011 Sep; 22(7):688-95. PubMed ID: 21945648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling mechanisms and functional roles of cofilin phosphorylation and dephosphorylation.
    Mizuno K
    Cell Signal; 2013 Feb; 25(2):457-69. PubMed ID: 23153585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways.
    Porter GW; Khuri FR; Fu H
    Semin Cancer Biol; 2006 Jun; 16(3):193-202. PubMed ID: 16697216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers.
    Reddy D; Kumavath R; Tan TZ; Ampasala DR; Kumar AP
    Life Sci; 2020 Jan; 241():117147. PubMed ID: 31830480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer.
    McCubrey JA; Rakus D; Gizak A; Steelman LS; Abrams SL; Lertpiriyapong K; Fitzgerald TL; Yang LV; Montalto G; Cervello M; Libra M; Nicoletti F; Scalisi A; Torino F; Fenga C; Neri LM; Marmiroli S; Cocco L; Martelli AM
    Biochim Biophys Acta; 2016 Dec; 1863(12):2942-2976. PubMed ID: 27612668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the 14-3-3 protein family in health, disease, and drug development.
    Aghazadeh Y; Papadopoulos V
    Drug Discov Today; 2016 Feb; 21(2):278-87. PubMed ID: 26456530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Par-4 dependent modulation of cellular β-catenin by medicinal plant natural product derivative 3-azido Withaferin A.
    Amin H; Nayak D; Ur Rasool R; Chakraborty S; Kumar A; Yousuf K; Sharma PR; Ahmed Z; Sharma N; Magotra A; Mukherjee D; Kumar LD; Goswami A
    Mol Carcinog; 2016 May; 55(5):864-81. PubMed ID: 25969134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chibby cooperates with 14-3-3 to regulate beta-catenin subcellular distribution and signaling activity.
    Li FQ; Mofunanya A; Harris K; Takemaru K
    J Cell Biol; 2008 Jun; 181(7):1141-54. PubMed ID: 18573912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3 Proteins--a focus on cancer and human disease.
    Wilker E; Yaffe MB
    J Mol Cell Cardiol; 2004 Sep; 37(3):633-42. PubMed ID: 15350836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 14-3-3 proteins as potential therapeutic targets.
    Zhao J; Meyerkord CL; Du Y; Khuri FR; Fu H
    Semin Cell Dev Biol; 2011 Sep; 22(7):705-12. PubMed ID: 21983031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14-3-3 proteins as potential oncogenes.
    Tzivion G; Gupta VS; Kaplun L; Balan V
    Semin Cancer Biol; 2006 Jun; 16(3):203-13. PubMed ID: 16725345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MOB (Mps one Binder) Proteins in the Hippo Pathway and Cancer.
    Gundogdu R; Hergovich A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31185650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of human TRM9L integrates multiple stress-signaling pathways for tumor growth suppression.
    Gu C; Ramos J; Begley U; Dedon PC; Fu D; Begley TJ
    Sci Adv; 2018 Jul; 4(7):eaas9184. PubMed ID: 30009260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlocking the code of 14-3-3.
    Dougherty MK; Morrison DK
    J Cell Sci; 2004 Apr; 117(Pt 10):1875-84. PubMed ID: 15090593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β signaling in cell fate control and cancer.
    Yu Y; Feng XH
    Curr Opin Cell Biol; 2019 Dec; 61():56-63. PubMed ID: 31382143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria as the decision makers for cancer cell fate: from signaling pathways to therapeutic strategies.
    Genovese I; Vezzani B; Danese A; Modesti L; Vitto VAM; Corazzi V; Pelucchi S; Pinton P; Giorgi C
    Cell Calcium; 2020 Dec; 92():102308. PubMed ID: 33096320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Crosstalk of Hippo/YAP and Wnt/β-catenin pathways].
    Xu F; Zhang J; Ma D
    Yi Chuan; 2014 Feb; 36(2):95-102. PubMed ID: 24846937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.